Related Experiment Video
Updated: Apr 11, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
[Infectious risk associated with new biological therapies : an update]
Adrien Calame1, Lorenzo Ciullini2, Eleftheria Kampouri3
1Service des maladies infectieuses, Hôpitaux universitaires de Genève, 1211 Genève 14.
Abstract:
The infectious risk associated with biological agents and targeted therapies is heterogeneous and depends on the immunological target, the underlying disease, host-related factors, and the level of cumulative immunosuppression. It may manifest as an increased frequency or severity of common infections, the occurrence of opportunistic infections, or the reactivation of latent infections. Understanding this risk is essential to implement appropriate preventive strategies, including screening, clinical and biological monitoring, optimization of vaccination status, and targeted prophylaxis. In high-risk patients, referral to a specialist consultation may be warranted. The aim of this article, an update of the 2020 publication, is to provide practical guidance on managing infectious risk in patients receiving immunosuppressive therapies.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Infectious Diseases and Their Occurrence
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

